US2005256174A1PendingUtilityA1
Raf kinase inhibitors
Individually held — no corporate assignee on recordPriority: May 23, 1997Filed: Jun 10, 2005Published: Nov 17, 2005
Est. expiryMay 23, 2017(expired)· nominal 20-yr term from priority
Inventors:Jill WoodHanno WildDaniel RogersJohn Francis LyonsMichael KatzYolanda CaringalRobert DallyWendy LeeRoger SmithCheri Blum
C07D 307/68A61P 35/00C07D 417/12C07D 471/04C07D 333/38C07D 207/34C07D 409/12
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods of treating tumors mediated by raf kinase, with substituted urea compounds, and such compounds per se.
Claims
exact text as granted — not AI-modified1 .- 17 . (canceled)
18 . A method for the treatment of cancerous cell growth mediated by raf kinase, comprising administering a compound of the formulae:
19 . A method according to claim 18 , comprising administering a compound of the formulae
20 . A method according to claim 18 , comprising administering a compound of the formulae
21 . A method according to claim 18 , comprising administering a compound of the formula
22 . A method according to claim 18 , comprising administering a compound of the formula
23 . A method according to claim 18 , comprising administering a compound of formulae
24 . A method according to claim 18 , comprising administering a compound of formulae
25 . A compound of the formulae
26 . A compound according to claim 25 , of the formulae
27 . A compound according to claim 25 , of the formulae
28 . A compound according to claim 25 , of the formula
29 . A compound according to claim 25 , of the formula
30 . A compound according to claim 25 , of the formulae
31 . A compound according to claim 25 , of the formulaeJoin the waitlist — get patent alerts
Track US2005256174A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.